Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIB Prostate Cancer AJCC v8”

222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 222 results

Large-scale testing (Phase 3)Ended earlyNCT00014586
What this trial is testing

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 110
Large-scale testing (Phase 3)Study completedNCT00023686
What this trial is testing

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 190
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00108732
What this trial is testing

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 50
Not applicableActive Not RecruitingNCT04985565
What this trial is testing

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00345813
What this trial is testing

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 62
Testing effectiveness (Phase 2)Study completedNCT01009736
What this trial is testing

Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy

Who this might be right for
Prostate Cancer
Ohio State University Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT00005072
What this trial is testing

Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Vical 25
Not applicableActive Not RecruitingNCT04189770
What this trial is testing

Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners

Who this might be right for
Cancer SurvivorPartnerSpouse+9 more
M.D. Anderson Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT00104741
What this trial is testing

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 378
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Not applicableActive Not RecruitingNCT04624256
What this trial is testing

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 208
Testing effectiveness (Phase 2)Study completedNCT03570827
What this trial is testing

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+3 more
Mayo Clinic 53
Early research (Phase 1)UnknownNCT00946543
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Royal Marsden NHS Foundation Trust 198
Large-scale testing (Phase 3)Ended earlyNCT00949962
What this trial is testing

Post-operative or Early Salvage XRT and ADT for High Risk PCa

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 87
Not applicableLooking for participantsNCT04775355
What this trial is testing

Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v7Stage II Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7+3 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00951535
What this trial is testing

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Who this might be right for
Prostate Cancer
Cancer Trials Ireland 251
Not applicableStudy completedNCT01992016
What this trial is testing

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more
University of Colorado, Denver 11
Testing effectiveness (Phase 2)Ended earlyNCT00348816
What this trial is testing

Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center at San Antonio 21
Next Page